R Bedimo

Summary

Country: USA

Publications

  1. ncbi request reprint Trends in AIDS-defining and non-AIDS-defining malignancies among HIV-infected patients: 1989-2002
    Roger Bedimo
    University of Alabama at Birmingham, USA
    Clin Infect Dis 39:1380-4. 2004
  2. ncbi request reprint Sustained HIV viral suppression following treatment interruption: an observational study
    Roger Bedimo
    University of Alabama, Birmingham, Alabama 85294, USA
    AIDS Res Hum Retroviruses 22:40-4. 2006
  3. ncbi request reprint Lipid abnormalities in HIV/hepatitis C virus-coinfected patients
    R Bedimo
    Department of Medicine, Division of Infectious Diseases, University of Texas South western Medical Center at Dallas, Dallas, TX 75216, USA
    HIV Med 7:530-6. 2006
  4. doi request reprint Abacavir use and risk of acute myocardial infarction and cerebrovascular events in the highly active antiretroviral therapy era
    Roger J Bedimo
    VA North Texas Health Care System, University of Texas Southwestern Medical Center, Dallas, Texas 75216, USA
    Clin Infect Dis 53:84-91. 2011
  5. doi request reprint Predictive value of HIV-1 replication capacity and phenotypic susceptibility scores in antiretroviral treatment-experienced patients
    R Bedimo
    Veterans Affairs North Texas Health Care System, Dallas, TX 75216, USA
    HIV Med 13:345-51. 2012
  6. doi request reprint Hepatitis C virus coinfection and the risk of cardiovascular disease among HIV-infected patients
    R Bedimo
    Department of Medicine, VA North Texas Health Care System, Dallas, 75216, USA
    HIV Med 11:462-8. 2010
  7. doi request reprint Lipid-lowering efficacy and safety after switching to atazanavir-ritonavir-based highly active antiretroviral therapy in patients with human immunodeficiency virus
    Sean T Nguyen
    Texas Tech University Health Sciences Center School of Pharmacy, Dallas Fort Worth Regional Campus, Dallas, Texas 75216, USA
    Pharmacotherapy 28:323-30. 2008
  8. doi request reprint Safety and efficacy of simvastatin for the treatment of dyslipidemia in human immunodeficiency virus-infected patients receiving efavirenz-based highly active antiretroviral therapy
    Anita P Rahman
    School of Pharmacy, Texas Tech University Health Sciences Center, Dallas Fort Worth Regional Campus, Dallas, Texas 75216, USA
    Pharmacotherapy 28:913-9. 2008
  9. ncbi request reprint Non-AIDS-defining malignancies among HIV-infected patients in the highly active antiretroviral therapy era
    Roger Bedimo
    VA North Texas Health Care System and University of Texas Southwestern Medical Center, 4500 South Lancaster Road, Dallas, TX 75216, USA
    Curr HIV/AIDS Rep 5:140-9. 2008
  10. doi request reprint Improvement in insulin sensitivity and dyslipidemia in protease inhibitor-treated adult male patients after switch to atazanavir/ritonavir
    Anthony J Busti
    Texas Tech University Health Sciences Center School of Pharmacy, Dallas, Texas, USA
    J Investig Med 56:539-44. 2008

Collaborators

Detail Information

Publications11

  1. ncbi request reprint Trends in AIDS-defining and non-AIDS-defining malignancies among HIV-infected patients: 1989-2002
    Roger Bedimo
    University of Alabama at Birmingham, USA
    Clin Infect Dis 39:1380-4. 2004
    ..87; P<.0002). The mean CD4 cell count was lower among patients with ADMs than among those with non-ADMs. A longer duration of survival during highly active antiretroviral therapy might explain the increasing incidence of non-ADMs...
  2. ncbi request reprint Sustained HIV viral suppression following treatment interruption: an observational study
    Roger Bedimo
    University of Alabama, Birmingham, Alabama 85294, USA
    AIDS Res Hum Retroviruses 22:40-4. 2006
    ..Examining the immune responses of nonrebounders may contribute to the understanding of protective immunity to HIV...
  3. ncbi request reprint Lipid abnormalities in HIV/hepatitis C virus-coinfected patients
    R Bedimo
    Department of Medicine, Division of Infectious Diseases, University of Texas South western Medical Center at Dallas, Dallas, TX 75216, USA
    HIV Med 7:530-6. 2006
    ..Among HIV-infected patients, hepatitis C virus (HCV) coinfection is associated with increased rates of lipodystrophy and insulin resistance. Its impact on HIV-associated dyslipidaemia is less clear...
  4. doi request reprint Abacavir use and risk of acute myocardial infarction and cerebrovascular events in the highly active antiretroviral therapy era
    Roger J Bedimo
    VA North Texas Health Care System, University of Texas Southwestern Medical Center, Dallas, Texas 75216, USA
    Clin Infect Dis 53:84-91. 2011
    ..Some studies have suggested that exposure to antiretroviral therapy (ART) with abacavir is associated with an increased risk of acute myocardial infarction (AMI)...
  5. doi request reprint Predictive value of HIV-1 replication capacity and phenotypic susceptibility scores in antiretroviral treatment-experienced patients
    R Bedimo
    Veterans Affairs North Texas Health Care System, Dallas, TX 75216, USA
    HIV Med 13:345-51. 2012
    ..The aim of the study was to determine the prognostic value of HIV replication capacity (RC) for subsequent antiretroviral (ARV) treatment response in ARV-experienced patients...
  6. doi request reprint Hepatitis C virus coinfection and the risk of cardiovascular disease among HIV-infected patients
    R Bedimo
    Department of Medicine, VA North Texas Health Care System, Dallas, 75216, USA
    HIV Med 11:462-8. 2010
    ..Among HIV-infected patients, hepatitis C virus (HCV) coinfection is associated with lower cholesterol levels, but it remains unclear how it affects cardiovascular outcomes...
  7. doi request reprint Lipid-lowering efficacy and safety after switching to atazanavir-ritonavir-based highly active antiretroviral therapy in patients with human immunodeficiency virus
    Sean T Nguyen
    Texas Tech University Health Sciences Center School of Pharmacy, Dallas Fort Worth Regional Campus, Dallas, Texas 75216, USA
    Pharmacotherapy 28:323-30. 2008
    ....
  8. doi request reprint Safety and efficacy of simvastatin for the treatment of dyslipidemia in human immunodeficiency virus-infected patients receiving efavirenz-based highly active antiretroviral therapy
    Anita P Rahman
    School of Pharmacy, Texas Tech University Health Sciences Center, Dallas Fort Worth Regional Campus, Dallas, Texas 75216, USA
    Pharmacotherapy 28:913-9. 2008
    ....
  9. ncbi request reprint Non-AIDS-defining malignancies among HIV-infected patients in the highly active antiretroviral therapy era
    Roger Bedimo
    VA North Texas Health Care System and University of Texas Southwestern Medical Center, 4500 South Lancaster Road, Dallas, TX 75216, USA
    Curr HIV/AIDS Rep 5:140-9. 2008
    ....
  10. doi request reprint Improvement in insulin sensitivity and dyslipidemia in protease inhibitor-treated adult male patients after switch to atazanavir/ritonavir
    Anthony J Busti
    Texas Tech University Health Sciences Center School of Pharmacy, Dallas, Texas, USA
    J Investig Med 56:539-44. 2008
    ..However, its effects on insulin sensitivity have not been elucidated. We conducted this study to test the hypothesis that ATV improves insulin resistance and dyslipidemia...
  11. ncbi request reprint The management of musculoskeletal infection in HIV carriers
    Jean Bahebeck
    University Hospitals of Yaoundé, Cameroon
    Acta Orthop Belg 70:355-60. 2004
    ..For those who are MID, the indication for antiretroviral therapy should depend on the presence of one or more AIDS-related signs...